Global Photopheresis Products Market Will Exhibit a 5.9% CAGR over the Period Between 2016 and 2024 Expected to Rise to US $371.1 Mn
The photopheresis products market is mainly driven by growing Graft versus host disease conditions globally. Furthermore the rising coverage of healthcare and increasing in transplantations expected to grow photopheresis products market growth. However, the market growth is hindered by lack of many photopheresis treatment centers and high cost involved in therapy. In the U.S., ECP therapy costs around US$8000/treatment and every individual has to take the treatment for every two weeks and continue the same procedure for one year to...
View full press release